These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 2940461)
21. The FML (Fucose Mannose Ligand) of Leishmania donovani. a new tool in diagnosis, prognosis, transfusional control and vaccination against human kala-azar. Palatnik de Sousa CB; Gomes EM; de Souza EP; dos Santos WR; de Macedo SR; de Medeiros LV; Luz K Rev Soc Bras Med Trop; 1996; 29(2):153-63. PubMed ID: 8713607 [TBL] [Abstract][Full Text] [Related]
22. Vaccination of Balb/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani. Paraguai de Souza E; Bernardo RR; Palatnik M; Palatnik de Sousa CB Vaccine; 2001 Apr; 19(23-24):3104-15. PubMed ID: 11312005 [TBL] [Abstract][Full Text] [Related]
23. Immunoblotting identifies an antigen recognized by anti gp63 in the immune complexes of Indian kala-azar patient sera. Sanyal T; Ghosh DK; Sarkar D Mol Cell Biochem; 1994 Jan; 130(1):11-7. PubMed ID: 8190117 [TBL] [Abstract][Full Text] [Related]
24. ELISA titres to polysaccharide antigens of Leishmania donovani promastigotes in kala-azar. Ray R; Ghose AC Trans R Soc Trop Med Hyg; 1986; 80(6):998. PubMed ID: 3603654 [No Abstract] [Full Text] [Related]
25. Immunoblot analysis of the antibody response to antigens of Leishmania donovani in Indian kala-azar. Salotra P; Raina A; Negi NS Br J Biomed Sci; 1999; 56(4):263-7. PubMed ID: 10795370 [TBL] [Abstract][Full Text] [Related]
26. Leishmania donovani: isolation of a concanavalin-A specific antigen and its evaluation for serodiagnosis of visceral leishmaniasis. Bhattacharya M; Banerjee N; Ghosh DK Ann Trop Med Parasitol; 1992 Aug; 86(4):341-5. PubMed ID: 1281399 [TBL] [Abstract][Full Text] [Related]
27. Lipophosphoglycan masks recognition of the Leishmania donovani promastigote surface by human kala-azar serum. Karp CL; Turco SJ; Sacks DL J Immunol; 1991 Jul; 147(2):680-4. PubMed ID: 2071901 [TBL] [Abstract][Full Text] [Related]
28. Identification of major antigens of Leishmania donovani using kala azar sera. Arora SK; Sehgal S Med Microbiol Immunol; 1989; 178(2):81-8. PubMed ID: 2733636 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of antibody responses in Indian kala-azar by immunoblot. Tiwari V; Jain A; Agarwal M; Mittal B; Pandey HP Biochem Mol Biol Int; 1995 Nov; 37(5):959-64. PubMed ID: 8624503 [TBL] [Abstract][Full Text] [Related]
30. Purification of two Leishmania donovani membrane proteins recognized by sera from patients with visceral leishmaniasis. Jaffe CL; Zalis M Mol Biochem Parasitol; 1988 Jan; 27(1):53-62. PubMed ID: 3343999 [TBL] [Abstract][Full Text] [Related]
31. Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin. Mukherjee M; Bhattacharyya A; Duttagupta S Med Sci Monit; 2002 Apr; 8(4):BR117-22. PubMed ID: 11951057 [TBL] [Abstract][Full Text] [Related]
32. Immune complex glomerulonephritis in experimental kala-azar. II: Detection and characterization of parasite antigens and antibodies eluted from kidneys of Leishmania donovani-infected hamsters. Sartori A; Roque-Barreira MC; Coe J; Campos-Neto A Clin Exp Immunol; 1992 Mar; 87(3):386-92. PubMed ID: 1544224 [TBL] [Abstract][Full Text] [Related]
33. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis. Melby PC; Yang J; Zhao W; Perez LE; Cheng J Infect Immun; 2001 Aug; 69(8):4719-25. PubMed ID: 11447143 [TBL] [Abstract][Full Text] [Related]
34. Immunoblot analysis of the humoral immune response to Leishmania donovani infantum polypeptides in human visceral leishmaniasis. Rolland-Burger L; Rolland X; Grieve CW; Monjour L J Clin Microbiol; 1991 Jul; 29(7):1429-35. PubMed ID: 1885738 [TBL] [Abstract][Full Text] [Related]
35. Bulk production and comparison of promastigote and amastigote antigens of Leishmania donovani for serodiagnosis and value of serum protein and immunoglobulin changes in diagnosis of kala-azar cases. Dutta GD; Dutta GP J Commun Dis; 1985; 17(1 Suppl):77-82. PubMed ID: 3831071 [No Abstract] [Full Text] [Related]
36. Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis. Saha S; Mazumdar T; Anam K; Ravindran R; Bairagi B; Saha B; Goswami R; Pramanik N; Guha SK; Kar S; Banerjee D; Ali N J Clin Microbiol; 2005 Mar; 43(3):1269-77. PubMed ID: 15750095 [TBL] [Abstract][Full Text] [Related]
37. Expression and characterization of a recombinant kinesin antigen from an old Indian strain (DD8) of Leishmania donovani and comparing it with a commercially available antigen from a newly isolated (KE16) strain of L. donovani. Sivakumar R; Dey A; Sharma P; Singh S Infect Genet Evol; 2008 May; 8(3):313-22. PubMed ID: 18374635 [TBL] [Abstract][Full Text] [Related]
38. Leishmanin test in post-kala-azar dermal leishmaniasis. Neogy AB; Nandy A; Chowdhury AB Trans R Soc Trop Med Hyg; 1990; 84(1):58. PubMed ID: 2345927 [No Abstract] [Full Text] [Related]
39. Cloning, expression and antigenicity of the L. donovani reductase. Jensen AT; Kemp K; Theander TG; Handman E APMIS; 2001 Jun; 109(6):461-8. PubMed ID: 11506479 [TBL] [Abstract][Full Text] [Related]
40. A diagnostic ELISA for visceral leishmaniasis, based on antigen from media conditioned by Leishmania donovani promastigotes. Martin SK; Thuita-Harun L; Adoyo-Adoyo M; Wasunna KM Ann Trop Med Parasitol; 1998 Jul; 92(5):571-7. PubMed ID: 9797830 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]